119 related articles for article (PubMed ID: 11988316)
1. Preservation of fertility and ovarian function and minimalization of chemotherapy associated gonadotoxicity and premature ovarian failure: the role of inhibin-A and -B as markers.
Blumenfeld Z
Mol Cell Endocrinol; 2002 Feb; 187(1-2):93-105. PubMed ID: 11988316
[TBL] [Abstract][Full Text] [Related]
2. 'An ounce of prevention is worth a pound of cure': the case for and against GnRH-agonist for fertility preservation.
Blumenfeld Z; Katz G; Evron A
Ann Oncol; 2014 Sep; 25(9):1719-1728. PubMed ID: 24651411
[TBL] [Abstract][Full Text] [Related]
3. Preservation of gonadal function in women undergoing chemotherapy: a systematic review and meta-analysis of the potential role for gonadotropin-releasing hormone agonists.
Hickman LC; Llarena NC; Valentine LN; Liu X; Falcone T
J Assist Reprod Genet; 2018 Apr; 35(4):571-581. PubMed ID: 29470701
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-Releasing Hormone (GnRH) Agonists Do Not Protect Ovarian Function in Patients Undergoing Stem Cell Transplants.
Benor A; Decherney A
Cureus; 2024 Apr; 16(4):e58387. PubMed ID: 38756303
[TBL] [Abstract][Full Text] [Related]
5. Maximizing ovarian function and fertility following chemotherapy in premenopausal patients: Is there a role for ovarian suppression?
Roof KA; Andre KE; Modesitt SC; Schirmer DA
Gynecol Oncol Rep; 2024 Jun; 53():101383. PubMed ID: 38633671
[TBL] [Abstract][Full Text] [Related]
6. Melatonin provides protection against cisplatin-induced ovarian damage and loss of fertility in mice.
Huang J; Shan W; Li N; Zhou B; Guo E; Xia M; Lu H; Wu Y; Chen J; Wang B; Xi L; Ma D; Chen G; Li K; Sun C
Reprod Biomed Online; 2021 Mar; 42(3):505-519. PubMed ID: 33388265
[TBL] [Abstract][Full Text] [Related]
7. Development of a fertility risk calculator to predict individualized chance of ovarian failure after chemotherapy.
Chung EH; Acharya CR; Harris BS; Acharya KS
J Assist Reprod Genet; 2021 Nov; 38(11):3047-3055. PubMed ID: 34495476
[TBL] [Abstract][Full Text] [Related]
8. Fertility protection: a novel approach using pretreatment with mesenchymal stem cell exosomes to prevent chemotherapy-induced ovarian damage in a mouse model.
Park HS; Seok J; Cetin E; Ghasroldasht MM; Liakath Ali F; Mohammed H; Alkelani H; Al-Hendy A
Am J Obstet Gynecol; 2024 Feb; ():. PubMed ID: 38378099
[TBL] [Abstract][Full Text] [Related]
9. Follicular reconstruction and neo-oogenesis in xenotransplantation of human ovarian isolated cells derived from chemotherapy-induced POF patients.
Khaleghi S; Eivazkhani F; Tavana S; Moini A; Novin MG; Stoyan P; Nazarian H; Fathi R
J Biol Eng; 2023 Nov; 17(1):70. PubMed ID: 37986177
[TBL] [Abstract][Full Text] [Related]
10. Bortezomib prevents acute doxorubicin ovarian insult and follicle demise, improving the fertility window and pup birth weight in mice.
Roti Roti EC; Ringelstetter AK; Kropp J; Abbott DH; Salih SM
PLoS One; 2014; 9(9):e108174. PubMed ID: 25251158
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic ovarian transplantation using immunomodulator preimplantation factor (PIF) as monotherapy restored ovarian function in olive baboon.
Feichtinger M; Barnea ER; Nyachieo A; Brännström M; Kim SS
J Assist Reprod Genet; 2018 Jan; 35(1):81-89. PubMed ID: 29128910
[TBL] [Abstract][Full Text] [Related]
12. Assessing risks and knowledge gaps on the impact of systemic therapies in early breast cancer on female fertility: A systematic review of the literature.
Gentile G; Scagnoli S; Arecco L; Santini D; Botticelli A; Lambertini M
Cancer Treat Rev; 2024 Jul; 128():102769. PubMed ID: 38810574
[TBL] [Abstract][Full Text] [Related]
13. Intermittent spontaneous ovulation in patients with premature ovarian failure: Three case reports and review of literature.
Zhang WY; Wang HB; Deng CY
World J Clin Cases; 2023 Nov; 11(31):7647-7655. PubMed ID: 38078130
[TBL] [Abstract][Full Text] [Related]
14. Patients with 47, XXX karyotype who experienced premature ovarian failure (POF): two case reports.
Sugawara N; Maeda M; Manome T; Nagai R; Araki Y
Reprod Med Biol; 2013 Oct; 12(4):193-195. PubMed ID: 29699146
[TBL] [Abstract][Full Text] [Related]
15. The future of fertility preservation for women treated with chemotherapy.
Alesi LR; Nguyen QN; Stringer JM; Winship AL; Hutt KJ
Reprod Fertil; 2023 Apr; 4(2):. PubMed ID: 37068157
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy induced oxidative stress in the ovary: drug-dependent mechanisms and potential interventions†.
Trujillo M; Odle AK; Aykin-Burns N; Allen AR
Biol Reprod; 2023 Apr; 108(4):522-537. PubMed ID: 36539327
[TBL] [Abstract][Full Text] [Related]
17. Anti-Mullerian hormone and inhibin B levels as markers of premature ovarian aging and transition to menopause in type 1 diabetes mellitus.
Soto N; Iñiguez G; López P; Larenas G; Mujica V; Rey RA; Codner E
Hum Reprod; 2009 Nov; 24(11):2838-44. PubMed ID: 19643804
[TBL] [Abstract][Full Text] [Related]
18. RNA N
Huang E; Chen L
Cell Commun Signal; 2023 Mar; 21(1):53. PubMed ID: 36894952
[TBL] [Abstract][Full Text] [Related]
19. Preservation of female fertility during cancer treatment.
Imai A; Furui T; Yamamoto A
Reprod Med Biol; 2008 Mar; 7(1):17-27. PubMed ID: 29699284
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
